October 07, 2022
2 min watch
Save
VIDEO: Presbyopes treated with Vuity show increase in near, intermediate vision
Issue: November 10, 2022
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
CHICAGO — In this Healio Video Perspective from the AAO meeting, Beeran B. Meghpara, MD, discusses 30-day data from the GEMINI 1 and GEMINI 2 studies.
The studies examined visual acuity responses to Vuity (pilocarpine HCl ophthalmic solution 1.25%, Allergan) in patients with presbyopia.
“Data showed that there was a significant increase in near and intermediate vision without compromising distance vision,” Meghpara said.
Published by:
Sources/Disclosures
Collapse
Source:
Meghpara BB, et al. Efficacy of pilocarpine HCl ophthalmic solution 1.25% in emmetropes and nonemmetropes in the 30-day GEMINI 1 and GEMINI 2 studies. Presented at: American Academy of Ophthalmology meeting; Sept. 30-Oct. 3, 2022; Chicago.
Disclosures:
Meghpara reports being a consultant and speaker for AbbVie/Allergan.
Read more about
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.